Affimed (AFMD) Misses Q2 EPS by 2c

Affimed (NASDAQ: AFMD) reported Q2 EPS of (EUR0.19), EUR0.02 worse than the analyst estimate of (EUR0.17). Revenue for the quarter came in at EUR2.2 million versus the consensus estimate of EUR2.57 million.

For earnings history and earnings-related data on Affimed (AFMD) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• MP Materials seen largely insulated after China export-control move
• Pfizer lung cancer drug misses survival goal in Phase 3 trial